… developed and successfully tested in animalmodels, and it is … a role in severe SARS-CoV-2 infections caused by cytokine … have been no studies utilizing neutralizingantibodies or the …
… screened human-mouse chimeric antibodies that neutralizeSARS-CoV-2 in this study, … potentSARS-CoV-2neutralizingantibodies and protection from disease in a small animalmodel[…
… was reviewed, the feasibility, safety and therapeuticeffect of different drug delivery routes for the … Nanobodies as powerful pulmonary targeted biotherapeutics against SARS-CoV-2, …
… The major severe acute respiratory symptom coronavirus 2 (SARS-CoV-2) subunit vaccines that have been marketed and are currently in the clinical stage are reviewed. The design …
… 本文综述SARS-CoV-2 中和抗体的研究进 展,为SARS-CoV-2疫情防控提供参考. … of potent SARS-CoV-2neutralizingantibodies and pro⁃ tection from disease in a small animalmodel[J]. …
… Nb has the advantages of high stability, strong hydrophilicity, easy … studies have shown that Nb has good therapeuticeffects on … Synthetic nanobodies targeting the sars-cov-2 receptor-…
… 本文对SARS-CoV-2与ACE2的相关作用机制进行了简单概述,… coronavirus-2 (SARS-CoV-2), with strong contagiousness, high … the development of neutralizingantibody drugs for emerging …
… Longitudinal isolation of potent near-germline SARS-CoV2-neutralizingantibodies from COVID-… A perspective on potential antibody-dependent enhancement of SARS-CoV2[J]. Nature, …